Go Deep
Nuvation Bio Inc.
Nuvation Bio Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 17,352 | -10.7 | 6.53 | 1.64 | 449.50 |
| Oct 2026 | 17,401 | -10.6 | 6.47 | 1.64 | 444.35 |
| Oct 2026 | 17,316 | -10.8 | 6.57 | 1.64 | 451.06 |
| Oct 2026 | 17,678 | -10.1 | 6.16 | 1.64 | 421.48 |
| Oct 2026 | 17,642 | -10.2 | 6.20 | 1.64 | 424.78 |
| Oct 2026 | 17,292 | -10.8 | 6.60 | 1.64 | 452.27 |
| Oct 2026 | 17,195 | -11.0 | 6.71 | 1.64 | 458.72 |
| Oct 2026 | 17,376 | -10.7 | 6.50 | 1.64 | 443.64 |
| Oct 2026 | 17,533 | -10.4 | 6.32 | 1.64 | 433.15 |
Nuvation Bio Inc. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 31,687,000.0 | 83,228,000.0 | 41,865,000.0 | 13,120,000.0 |
| Net Profit | -62,840,000.0 | 5,397,000.0 | -36,592,000.0 | -55,792,000.0 |
| EPS | -0.2 | 0.0 | -0.1 | -0.2 |
Nuvation Bio Inc. Revenue & Profit: Last 5 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Revenue | 62,902,000.0 | 7,873,000.0 | 0.0 | 0.0 | — |
| Net Profit | -204,627,000.0 | -567,939,000.0 | -75,802,000.0 | -104,199,000.0 | — |
| EPS | -0.6 | -2.1 | -0.3 | -0.5 | — |
Nuvation Bio Inc. Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 594,822,000.0 | 540,626,000.0 | 621,484,000.0 | 672,141,000.0 | — |
| Total Liabilities | 289,106,000.0 | 76,838,000.0 | 16,362,000.0 | 17,065,000.0 | — |
| Total Equity | 305,716,000.0 | 463,788,000.0 | 605,122,000.0 | 655,076,000.0 | — |
Owes vs Owns
Nuvation Bio Inc. owed $0.66 for every $1 it owned in Jun 2026, up from $0.03 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.66× | 0.49× | 0.14× | 0.03× | 0.03× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Nuvation Bio Inc. Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 89.0%Receivables 3.3%Inventory 1.9%Fixed assets (tangible) 0.8%Intangible assets 1.9%Other assets 3.2%
How it's funded — Dec 2025
Short-term debt 1.0%Long-term debt 7.9%Payables 1.6%Other liabilities 38.1%Shareholders' equity 51.4%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 529.2 | 502.7 | 611.2 | 661.0 |
| Receivables | 19.4 | 16.3 | 3.7 | 2.5 |
| Inventory | 11.4 | 0.0 | 0.0 | 0.0 |
| Fixed assets (tangible) | 4.5 | 3.0 | 4.3 | 4.7 |
| Intangible assets | 11.2 | 4.6 | 0.0 | 0.0 |
| Long-term investments | 0.0 | 0.0 | 0.0 | 0.0 |
| Other assets | 19.1 | 14.0 | 2.2 | 4.0 |
| Liabilities & equity | ||||
| Short-term debt | 5.7 | 6.3 | 2.0 | 1.2 |
| Long-term debt | 47.2 | 1.0 | 2.0 | 3.1 |
| Payables | 9.5 | 6.3 | 2.2 | 2.1 |
| Other liabilities | 226.7 | 63.2 | 10.1 | 10.7 |
| Shareholders' equity | 305.7 | 463.8 | 605.1 | 655.1 |
| Net tangible assets | 294.5 | 459.2 | 605.1 | 655.1 |
Nuvation Bio Inc. Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | -173,427,000.0 | -130,413,000.0 | -67,999,000.0 | -96,108,000.0 | — |
| Investing Activities | 99,520,000.0 | 122,703,000.0 | 8,921,000.0 | 63,457,000.0 | — |
| Financing Activities | 202,535,000.0 | 331,000.0 | 628,000.0 | 1,327,000.0 | — |